Cargando…
Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
INTRODUCTION: Burkitt's lymphoma (BL) is a virus associated childhood B-cell cancer common in Eastern Africa. Continued survival of B-cells in germinal centres depend on expression of high affinity immunoglobulins (Ig) to complementary antigens by somatic hypermutation of Ig genes. Cellular mic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Makerere Medical School
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040314/ https://www.ncbi.nlm.nih.gov/pubmed/32127902 http://dx.doi.org/10.4314/ahs.v19i4.48 |
_version_ | 1783500960591511552 |
---|---|
author | Ndede, Isaac Mining, SK Patel, K Wanjala, FM Tenge, C |
author_facet | Ndede, Isaac Mining, SK Patel, K Wanjala, FM Tenge, C |
author_sort | Ndede, Isaac |
collection | PubMed |
description | INTRODUCTION: Burkitt's lymphoma (BL) is a virus associated childhood B-cell cancer common in Eastern Africa. Continued survival of B-cells in germinal centres depend on expression of high affinity immunoglobulins (Ig) to complementary antigens by somatic hypermutation of Ig genes. Cellular microRNAs, non-coding RNAs have been reported to play role in cell cycle regulation. Both viral antigen dependent mutation and micro-RNA expression maybe involved in BL pathogenesis. OBJECTIVE: To describe immunoglobulin heavy variable (IgHV) rearrangement and micro-RNA expressions in BL tumours. METHODS: Genomic DNA were extracted and purified from BL tissue blocks at Moi Teaching and Referral Hospital, before amplification using IgHV consensus primers and sequencing. The sequences were then aligned with germline alleles in IMGT/V-QUEST® database. Total RNA extracted from tissue blocks and cell lines were used to determine relative expression of hsamiR-34a and hsa-miR-127. RESULTS: In all tumours, allele alignment scores and number of mutations range were 89.2–93.2%, 15–24 respectively. The range of IgHV amino acid changes were higher in EBER-1+ (15–25) than EBER-1- (9–15). In MYC+ tumours, the relative expression were: hsa-miR-127(2.09);hsa-miR-34a (2.8) and MYC- hsa-miR-127 (1.2), hsa-miR-34a (1.0). CONCLUSION: B-cell in BL contained somatic mutated IgHV gene and upregulated cellular microRNAs with possible pathogenetic role(s). |
format | Online Article Text |
id | pubmed-7040314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Makerere Medical School |
record_format | MEDLINE/PubMed |
spelling | pubmed-70403142020-03-03 Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya Ndede, Isaac Mining, SK Patel, K Wanjala, FM Tenge, C Afr Health Sci Articles INTRODUCTION: Burkitt's lymphoma (BL) is a virus associated childhood B-cell cancer common in Eastern Africa. Continued survival of B-cells in germinal centres depend on expression of high affinity immunoglobulins (Ig) to complementary antigens by somatic hypermutation of Ig genes. Cellular microRNAs, non-coding RNAs have been reported to play role in cell cycle regulation. Both viral antigen dependent mutation and micro-RNA expression maybe involved in BL pathogenesis. OBJECTIVE: To describe immunoglobulin heavy variable (IgHV) rearrangement and micro-RNA expressions in BL tumours. METHODS: Genomic DNA were extracted and purified from BL tissue blocks at Moi Teaching and Referral Hospital, before amplification using IgHV consensus primers and sequencing. The sequences were then aligned with germline alleles in IMGT/V-QUEST® database. Total RNA extracted from tissue blocks and cell lines were used to determine relative expression of hsamiR-34a and hsa-miR-127. RESULTS: In all tumours, allele alignment scores and number of mutations range were 89.2–93.2%, 15–24 respectively. The range of IgHV amino acid changes were higher in EBER-1+ (15–25) than EBER-1- (9–15). In MYC+ tumours, the relative expression were: hsa-miR-127(2.09);hsa-miR-34a (2.8) and MYC- hsa-miR-127 (1.2), hsa-miR-34a (1.0). CONCLUSION: B-cell in BL contained somatic mutated IgHV gene and upregulated cellular microRNAs with possible pathogenetic role(s). Makerere Medical School 2019-12 /pmc/articles/PMC7040314/ /pubmed/32127902 http://dx.doi.org/10.4314/ahs.v19i4.48 Text en © 2019 Ndede et al. Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Ndede, Isaac Mining, SK Patel, K Wanjala, FM Tenge, C Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya |
title | Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya |
title_full | Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya |
title_fullStr | Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya |
title_full_unstemmed | Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya |
title_short | Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya |
title_sort | immunoglobulin heavy variable (ighv) gene mutation and micro-rna expression in burkitt's lymphoma at moi teaching and referral hospital in western kenya |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040314/ https://www.ncbi.nlm.nih.gov/pubmed/32127902 http://dx.doi.org/10.4314/ahs.v19i4.48 |
work_keys_str_mv | AT ndedeisaac immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya AT miningsk immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya AT patelk immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya AT wanjalafm immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya AT tengec immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya |